Showing results (201-210 of 226) with videos related to
Sort By:
Pageof 23
Open Forum Infectious Diseases|November 29, 2023
Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and OutcomesJulio A Ramirez, Thomas R Chandler, Stephen P Furmanek, et al.Journal of Global Antimicrobial Resistance|November 17, 2021
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacinSusanne Paukner, Lisa Goldberg, Elizabeth Alexander, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2017
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1David B Huang, William O'Riordan, J Scott Overcash, et al.Plos One|February 27, 2013
Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in miceJeremy V Camp, Yong-Kyu Chu, Dong-Hoon Chung, et al.Open Forum Infectious Diseases|March 11, 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 StudyMichelle L Brown, Johann Motsch, Keith S Kaye, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2009
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of AmericaScott A Harper, John S Bradley, Janet A Englund, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative DesignJohn M McLaughlin, Qin Jiang, Raul E Isturiz, et al.Antimicrobial Agents and Chemotherapy|March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)Thomas L Holland, William O'Riordan, Alison McManus, et al.Chest|August 29, 2020
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert PanelMathias W Pletz, Francesco Blasi, James D Chalmers, et al.The University of Louisville Journal of Respiratory Infections|April 11, 2017
Using cluster analysis of cytokines to identify patterns of inflammation in hospitalized patients with community-acquired pneumonia: a pilot studyTimothy L Wiemken, Robert R Kelley, Rafael Fernandez-Botran, et al.Pageof 23